Introduction
============

*Staphylococcus aureus* is among the most challenging bacterial pathogens that cause various types of infections mainly in humans but also in animals ([@B82]; [@B71]). It has developed resistance to virtually all categories of antibiotic available for clinical use, but only methicillin-resistant *S. aureus* (MRSA) has reached epidemic proportions globally and has become a major worldwide problem ([@B60]). MRSA strains are common both in nosocomial and in community settings ([@B6]). The limitation of effective MRSA treatment options with antibiotics often leads to the development of chronic infections and is a cause of increased mortality, longer hospital stays and higher health care costs as compared to methicillin-sensitive *S. aureus* (MSSA) strains ([@B19]; [@B21]).

One of the alternative approaches to curing infections with antibiotic-resistant *S. aureus* strains is the use of lytic bacteriophages ([@B9]; [@B41]). These are natural parasites of bacteria that can specifically infect and kill their host but are harmless to eukaryotic cells. Numerous cases of successful treatment of *S. aureus* infections with bacteriophages in animals ([@B38]; reviewed by [@B7]) and in humans ([@B25],[@B26]; [@B58],[@B59]; [@B76]; [@B65]; [@B28]; [@B29]; reviewed by [@B41]) have been described.

Several phages from the order *Caudovirales*, of a complex virion structure comprising head and tail, are obligatorily lytic on *S. aureus* hosts and cannot transfer bacterial DNA by transduction. Thus, they can potentially be used in therapy (reviewed by [@B54]). Most of them have a long, contractile tail and have been currently classified to the family *Herelleviridae* ([@B8]). Some, less numerous and including only 14 isolates of sequenced genomes have a short tail ([@B98]; [@B45]; [@B81]; [@B43]; [@B90]; [@B101]; [@B35]). They belong to the *Picovirinae* subfamily of family *Podoviridae* ([@B47]). Those that infect *S. aureus* are much alike, despite being isolated in different geographical regions ([@B43]), and have been affiliated to the *Rosenblumvirus* genus, subfamily *Picovirinae* (formerly 44AHJD-like phages or 68-like phages) ([@B47]; [@B35]).

The best known representative of *Picovirinae* is a model *Bacillus* phage phi29. However, the similarities between phi29 and the staphylococcal *Picovirinae* are limited to a similar genome size (17--20 kb) and tail morphology, partially conserved synteny between the genomes and the presence of terminal DNA repeats, protein-primed DNA replication and also structural homologies between certain proteins ([@B98]; [@B47]; [@B43]). Functions of about half of the proteins encoded by the staphylococcal phages could be predicted based on their homology. The major head protein, receptor binding protein (RBP) and two virion proteins of unknown function were identified by proteomic studies ([@B96]; [@B86]).

The interactions of the staphylococcal *Picovirinae* phages with their host cells are only beginning to be understood. Their adsorption to the cell surface requires a specific glycosylation pattern of the wall teichoic acid (WTA), which depends on the activity of *tarM-* or *tarS*-encoded glycosyltransferases catalyzing α-*O*-GlcNAcylation and β-*O*-GlcNAcylation of WTA, respectively ([@B49]). Studies on the adsorption requirements of various *Rosenblumvirus* phages and the results of phylogenetic analysis of their RBPs allowed distinguishing two subgroups: phages that require β-*O-*GlcNAcylation of WTA for adsorption (SAP-2, SLPW, S13′, SCH1, Psa3, GRCS, 44AHJD, P68 and 66), and phages that adsorb to α-*O*-GlcNAcylated as well as β-*O*-GlcNAcylated WTA (S24-1 and BP39) ([@B49]; [@B96]). Consistent with the adsorption-promoting TarS-mediated WTA modification and adsorption-inhibiting TarM-mediated WTA modification some phages of subgroup I have also been shown to infect strains of *Staphylococcus xylosus* and *Staphylococcus equorum*, which encode homologs of *S. aureus* TarS but lack genes encoding homologs of TarM ([@B49]). A phage tail lysin contributes to the penetration of phage DNA into the host cell. Another protein is associated with the DNA ends ([@B98]). Based on the homologies between DNA polymerases and between certain structural proteins of phi29 and *Rosenblumvirus* phages the lytic development of the latter is assumed to be similar to that of phi29, albeit it has not been studied. Cell lysis allowing phage release depends on phage endolysin, whose gene is located within a cluster of morphogenesis genes, unlike in phi29 ([@B47]).

Studies on the antistaphylococcal activity of *Rosenblumvirus* genus phages *in vivo* are sparce. One of these phages, S13', was demonstrated to have a life-prolonging effect on *S. aureus*-infected silkworm larvae and protected about 40--50% of mice infected with *S. aureus* from death, including the death from lung-derived septicemia ([@B92], [@B93]). Endolysin of another phage, SAP-2, was active in decreasing the biofilm mass of various *S. aureus* and *S. epidermidis* strains, as estimated in visual assay experiments ([@B81]). Its lytic activity against various strains was wider than that of the parental phage. Little is known about the phage--bacteria interactions leading to severe limitation of bacterial growth without, however, threatening the phage with extinction due to elimination of its host. To fill in this gap we characterized here an additional phage of this genus, phiAGO1.3. We have identified its properties contributing to the wide host-strain range, and show its atypical strategy of co-existence with the host. Additionally, we demonstrate that this strategy not only does not preclude the antistaphylococcal activity of phiAGO1.3 *in vivo* but even leads to the selection of bacterial mutants of attenuated virulence.

Materials and Methods {#s1}
=====================

Phage, Bacterial, and Nematode Strains and Culture Conditions
-------------------------------------------------------------

*Staphylococcus aureus* podovirus vB_SauP_phiAGO1.3 (phiAGO1.3) used in this study was isolated earlier by us from Warsaw sewage ([@B34]; [@B35]). However, using primers specific for temperate phages of various integrase types ([@B33]) we identified a prophage/phage of Φ55 integrase type in the bacterial strain used for phiAGO1.3 propagation (2064/05), and in the phiAGO1.3-derived lysates of this strain (data not shown). To avoid contamination with this phage, strain 80wphwpl, which had been cured of active prophages and plasmids and whose genomic sequence had been determined ([@B55]) was used for phiAGO1.3 propagation in the present study. The monoclonality of the starting phiAGO1.3 preparations obtained from 80wphwpl cells was confirmed by negative results of PCR with a primer pair specific for the 2064/05-derived prophage (data not shown). Another phage used in this study, A5W, is a representative of *Kayvirus* genus and was described previously ([@B54]). The list of *Staphylococcus* spp. reference strains and *S. aureus* strains used in this study is given in Supplementary Table [1](#SM1){ref-type="supplementary-material"} and Figure [1](#F1){ref-type="fig"}, respectively. Of 75 *S. aureus* strains used, 74 strains came from the MICROBANK collection of the National Medicines Institute (NMI), Warsaw, Poland. Sixty six of them comprised clinical strains isolated from inpatients between 1999 and 2011. Eight of them were from nasal colonization in human (*n* = 5), from environmental samples (*n* = 2), and from bovine mastitis (*n* = 1). The isolates were characterized, at the phenotypic and molecular level; they represented 14 genetic lineages (MLST-Clonal Compexes \[CCs\]: CC1, CC5, CC7, CC8, CC8/239, CC9, CC15, CC22, CC30, CC45, CC59, CC97, CC121, and CC398). Thirty five isolates resistant to methicillin (MRSA) were assigned to 27 MRSA clones. They included hospital-, community- or livestock-associated representatives of 10 CCs (CC1, CC5, CC7, CC8, CC8/239, CC22, CC30, CC45, CC59, and CC398). Methicillin-susceptible *S. aureus* (MSSA) isolates (*n* = 39) belonged to all CCs with the exception of CC8/239. *S. aureus* strain RN4220 (CC8) is a restriction-modification deficient and prophage-free derivative of NCTC8325 described previously ([@B44]; [@B69]). Bacteria were grown at 37°C with constant shaking (200 rpm) in Luria-Bertani broth (LB; Difco), in brain heart infusion broth (BHI; Oxoid) or in trypticase soy broth (TSB; Difco), as indicated.

A standard laboratory *Caenorhabditis elegans* strain Bristol N2 (wild-type) was used as a model host for *S. aureus* infection in all experiments. It was obtained from the Caenorhabditis Genetics Center (CGC), University of Minnesota. The nematodes were maintained on NGM agar medium and fed *E. coli* strain OP50 as described elsewhere ([@B87]).

Phage Propagation
-----------------

To ensure the lack of contamination of phiAGO1.3-containing cell lysates with temperate phages or plasmid DNA the phage that was originally obtained by propagation in *S. aureus* 2064/05 ([@B35]) was passaged several times from a single plaque through *S. aureus* 80wphwpl, and lysates were verified for the absence of 2064/05-derived phage DNA by PCR with 2064/05-prophage (integrase type Φ55) specific primer pair ([@B33]). Only confirmed monoclonal lysates were used for phiAGO1.3 propagation on a larger scale in 80wphwpl cells.

Phage Purification
------------------

Cell lysate containing phages (50 ml, 10^11^ PFU/ml) was filtered through 0.22-μm pore size membrane (MILLEX^®^ GS) and treated with RNase A (PureLink RNase, Invitrogen) and DNase (Turbo DNase, Ambion) (final concentration 20 μg/ml of each) at 37°C for 2 h. Next, the lysate was supplemented with polyethylene glycol (PEG6000) and NaCl to final concentrations of 10% and 1 M, respectively, and incubated on ice for 24 h. Samples were centrifuged (10,000 × *g*, 30 min, 4°C) and the pellet was resuspended in phosphate buffered saline (PBS: 10 mM Na~2~HPO~4~, 137 mM NaCl, 2.7 mM KCl, 2 mM KH~2~PO~4~ at pH 7.4).

Determination of Bacteriophage Host Range With a Spot Test
----------------------------------------------------------

Overnight cultures of various *S. aureus* strains in LB medium (0.2 ml) were supplemented with CaCl~2~ and MgSO~4~ to the final concentration of 2.5 mM each, mixed with 1 ml LB and 8 ml molten LCA (55°C), overlaid on LB agar medium in Petri dishes, and left to solidify. Lysates containing phages were standardized by diluting in LB to obtain the titer of 10^8^, 10^6^, and 10^4^ PFU/ml. Ten microliters of each lysate at each dilution was spotted on the cell layer of each strain. Plates were incubated overnight at 37°C, and the number and morphology of plaques were determined.

Assays of Bacteriophage Lytic Activity in Liquid Cultures of *S. aureus*
------------------------------------------------------------------------

Overnight cultures of various *S. aureus* strains were diluted 1:100 in fresh LB medium supplemented with CaCl~2~ and MgSO~4~ (2.5 mM each). Aliquots of each culture (190 μl) were added to wells of sterilized honeycomb plates and incubated in a Bioscreen C Microbiology Plate Reader (Growth Curves USA, Piscataway Township, NJ, United States) at 37°C until the optical density (OD~600~) reached ca. 0.2. The cultures were then supplemented with the phage at MOI of about 0.1 and 1 by the addition of 10 μl of an appropriately diluted lysate or LB (control samples). The cultures were left for 10 min at room temperature (RT) without shaking to allow for phage adsorption, and then were incubated as above with medium intensity shaking for 24 h. The optical density of the cultures was measured during the whole experiment in 15-min intervals.

Assay of Bacteriophage Influence on Preformed *S. aureus* Biofilms
------------------------------------------------------------------

The ability of phiAGO1.3 to disrupt preformed *S. aureus* biofilm was assayed as described previously ([@B83]), with some modifications. *S. aureus* scraped from fresh LB agar plate was inoculated in 1 ml of BHI containing 2% sucrose, incubated overnight at 37°C without shaking and diluted 1:100 in fresh medium. Aliquots of bacterial suspension (100 μl) were transferred to wells of sterile 96-well flat-bottom polystyrene plates (Greiner Bio-One, Germany) containing a preformed fibrinogen layer (50 μg fibrinogen in 100 μl of water per well, incubated for 24 h at 4°C and carefully aspirated). Bacterial biofilm was allowed to form for 24 h at 37°C without agitation. The wells were then carefully washed twice with 200 μl of phosphate buffered saline (PBS). Next, 100 μl of diluted bacterial lysate containing phage (10^8^ PFU/ml) or LB (control) was added, the plates were incubated for 24 h as above and washed twice with PBS. The biofilm was fixed with 200 μl of 99% methanol for 15 min, drained, left to dry at 50°C for 1 h, and then stained with 0.01% crystal violet (CV; 200 μl) for 15 min. Excess CV was removed by washing three times with water and the wells were air-dried. The amount of CV bound by the biofilm was quantified by solubilizing in 200 μl of 33% acetic acid for 10 min followed by determination of the optical density of the obtained solution at 570 nm using a microplate reader (Bio-tek Synergy^TM^ HT).

Killing Assay
-------------

The fraction of bacteria surviving phage infection was determined by killing assay, as described previously ([@B13]; [@B2]), with some modifications. Briefly, 80wphwpl culture (10 ml, OD~600~ of about 0.4) was infected with phiAGO1.3 at MOI 1 and 10 and left for 15 min at RT to allow for phage adsorption. The same volume of uninfected culture was used as a control. Samples were placed on ice, immediately serially diluted 10-fold in cold LB and spread on LB agar plates. The plates were incubated at 37°C for 24 h and bacterial colonies formed were counted. The fraction of surviving cells was calculated based on the ratio between the number of colonies formed by cells from infected and uninfected cultures.

Identification of Phage-Releasing Colonies
------------------------------------------

Single *S. aureus* colonies recovered following phage infection described as above, were transferred onto a top agar overlay of strain 80wphwpl, incubated overnight at 37°C and checked for the presence of a lysis zone -- a hallmark of spontaneous phage release. The presence of phiAGO1.3 was additionally verified by PCR with phage-specific primers. Briefly, candidate colonies were suspended in 100 μl of ice-cold water, and 1 μl of the suspension was used as a source of template for the DNA amplification with primers OMLO707 5′-TGCATGGCTTGTTTTGCTAAAGC-3′ and OMLO708 5′-ACAAGCWGGACAACCGTCTTGGT-3′. PCR conditions were as follows: 95°C for 15 min (95°C for 30 s, 55°C for 30 s, 75°C for 1 min) × 30, 75°C for 7 min.

Determination of Phage Carrier State Stability
----------------------------------------------

To evaluate the stability of the phage carrier state the fraction of cells retaining phiAGO1.3 following consecutive cell divisions was determined. Briefly, phage-releasing colony (designated as FTpt further in this manuscript) identified as above was suspended in 100 μl of cold water, placed on ice, immediately serially diluted 10-fold in cold LB and spread on LB agar plates. The plates were incubated at 37°C for 24 h, and colonies formed (designated as first generation: G~1~) were transferred onto a top agar overlay of strain 80wphwpl. After overnight incubation at 37°C, the percentage of phage-producing colonies (FTpt) in G~1~ population was determined. The procedure was repeated six times starting each time from cells of one phage-producing colony.

Evaluation of phiAGO1.3 Efficacy in Curing *S. aureus-*Infected Nematodes
-------------------------------------------------------------------------

The ability of phiAGO1.3 to cure nematodes infected with *S. aureus* 80wphwpl was assayed as previously described ([@B53]), with some modifications. An overnight tryptic soy broth (TSB) bacterial culture was diluted 1:100 in fresh medium and 100 μl was spread on a 5.5-cm diameter tryptic soy agar (TSA) plate and incubated at 37°C for 24 h. *C. elegans* larvae at T4 stage taken from a synchronized culture were transferred to a lawn of *S. aureus* cells and incubated at 25°C for 24 h. The infected nematodes were then rinsed from the plates, placed on a nylon mesh (CellMicroSieves, BioDesign) with 10-μm pores, washed twice with 5 ml of LB medium, and transferred onto a TSA plate. Then, they were covered with 5 ml of phage lysate (10^9^ PFU/ml) or LB medium (control), and incubated at RT for 1 h. The nematodes were then washed on a nylon mesh as above, transferred onto a TSA plate and left to dry. Twenty worms were picked randomly using a platinum wire pick and transferred to a fresh TSA plate. The plates were incubated at 25°C and scored for live and dead worms in 24-h intervals.

Isolation of *S. aureus* DNA
----------------------------

Bacteria were harvested from overnight cultures (3 ml) by centrifugation (10,000 × *g* for 10 min) and resuspended in 200 μl of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Lysostaphine (Sigma) and RNase (Invitrogen) was added to 200 and 10 μg/ml, respectively, the sample was shaked vigorously and incubated at 37°C until the culture lysed. DNA was extracted using the EXTRACTME kit for genomic DNA isolation from bacteria (Blirt DNA-Gdańsk, Poland), according to manufacturer's guidelines. DNA quality and quantity was checked by agarose gel electrophoresis.

*S. aureus* Genomic DNA Sequencing, and Sequence Assembly and Analysis
----------------------------------------------------------------------

*Staphylococcus aureus* genomic DNA was sheared mechanically to ∼600--700 bp and used for Paired-End TruSeq-like library construction using a KAPA Library preparation kit (KAPA/Roche, Basel, Switzerland) following manufacturer's instructions. The library was sequenced in the paired-end mode (v3, 600 cycle chemistry kit) on a MiSeq instrument (Illumina, San Diego, CA, United States). Sequence reads were filtered by quality using the ultra-fast FASTQ preprocessing toolkit, fastp version 0.14.1 ([@B16]^[1](#fn01){ref-type="fn"}^). As an additional stage, performed only for the clone of control 80wphwpl strain used in this study (designated as 80wphwpl_v1), long reads were generated to aid genome assembly using a MinION nanopore sequencing instrument (Oxford Nanopore Technologies, Oxford, United Kingdom). Approximately 1 μg of unsheared DNA was used for library preparation using the ONT Rapid Barcoding sequencing kit (SQK-RBK004). Nanopore sequencing was performed using the NC_48h_Sequencing_Run_FLO-MIN106_SQK-RBK004 protocol (MinKnow version 2.2) and R9.4.1 MinION flowcell. Raw nanopore data was basecalled using Albacore v2.3.1 (Oxford Nanopore Technologies, Oxford, United Kingdom). Following quality filtering and sequencing adapter removal using Porechop^[2](#fn02){ref-type="fn"}^ 17,527 barcoded reads remained. The median read length of the obtained dataset (132,564,821 of bases in total) was 5,649 bases. Long nanopore reads were assembled in a hybrid mode with the Illumina data using Unicycler v.0.4.6 ([@B103]). Genome hybrid assembly resulted in a single circular replicon. The suspected errors in the genome assembly, especially in genes containing tandem repeats, were verified by PCR amplification of relevant DNA fragments followed by Sanger sequencing on an ABI3730xl Genetic Analyzer (Life Technologies, United States) using BigDye Terminator Mix v. 3.1 chemistry (Life Technologies, United States). Missassemblies were further corrected using Seqman software (DNAStar, United States) to obtain the complete nucleotide sequence of 80wphwpl_v1 (2,732,618 bp). This newly generated consensus sequence of the parent strain genome was used as a template for the genomic sequence assembly of the *S. aureus* isolates resistant to infection with phiAGO1.3. Desktop software Geneious 11.0.4 (Biomatters, Ltd., Auckland, New Zealand) was used for the assembly. The alignments obtained served for the detection of differences between the mutants and the parental strain. Additional inspection of the sequence reads in the alignments served to exclude the ambiguities in the consensus sequence of the reference and mutant strains in the regions of detected mutations.

Results
=======

Basic Characteristics of phiAGO1.3
----------------------------------

Bacteriophage phAGO1.3 was originally isolated from sewage as an obligatorily lytic phage capable of infecting most *S. aureus* strains from a small collection of clinical isolates ([@B35]).

Measurement of typical phage growth parameters revealed that phiAGO1.3 could be a potential candidate for therapeutic applications. It can adsorb quickly to its host cells and has a short latent period (∼30 min) (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}). Its burst size was estimated to be about 35. Additionally, its titer in the lysate did not change significantly after 1 h of incubation at 37 or 50°C or at pH from 5 to 9 (Supplementary Figure [2](#SM1){ref-type="supplementary-material"}). Only incubation at temperatures of 60°C or higher or at pH below four or above 10 caused a drastic decrease of the phage activity. The optimal MOI for phiAGO1.3 propagation in *S. aureus* 80wphwpl was determined to be 0.01 (data not shown).

Coding Potential of phiAGO1.3 and Analysis of Its Structural Proteome
---------------------------------------------------------------------

The genome of phiAGO1.3 encodes 20 proteins ([@B35]). Their homologs are found in various *Picovirinae* that infect *S. aureus.* Phages GRCS and PSa3, which, respectively, encode eight and seven of them, appear to be the closest relatives of phiAGO1.3 at the protein sequence level (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). Close homologs of all phiAGO1.3 proteins are also encoded by prototypical *Rosenblumvirus* phages 44AHJD or 68. Eleven of the phiAGO1.3 proteins are virion components, as identified by a mass spectrometry analysis of tryptic peptides of whole virions (Supplementary Table [3](#SM1){ref-type="supplementary-material"}). Homologs of nine of them, including the major capsid protein, two tail proteins, lower and upper collar protein, RBP and tail amidase, have been identified or predicted previously as virion proteins of related phages ([@B98]; [@B92]; [@B95]; [@B86]). The two additional virion proteins of phiAGO1.3 identified in this work (ORF01 and ORF07) are present in virions in a small amount as suggested by the small number of their peptides in analyzed samples (Supplementary Table [3](#SM1){ref-type="supplementary-material"}). They have counterparts in related staphylococcal phages, but do not have apparent homologies to proteins of known function. One of them could act as the terminal protein priming the phage DNA replication, by analogy to phi29. DNA termini of phage 68, closely related to phiAGO1.3, have been shown to be covalently bound to a protein ([@B98]). A virion protein of phiAGO1.3 that might somehow contribute to the host specificity is ORF20. It appears to be, besides the tail fiber protein (ORF13), the most variable part of *S. aureus Rosenblumvirus* phages' virions. It is a highly acidic protein, which in phiAGO1.3 contains six repeats of ES/LTE amino acid sequence motif. The variability of ORF20 and its homologs in *S. aureus* phages results partly from the differences in the number of these repeats.

Determination of phiAGO1.3 Lytic Spectrum
-----------------------------------------

Certain polyvalent staphylococcal phages infect representatives of various *Staphylococcus* sp. Thus, we tested the sensitivity of 12 selected type strains of *Staphylococcus* spp. other than *S. aureus* to phiAGO1.3 (Supplementary Table [1](#SM1){ref-type="supplementary-material"}). The phage infected productively one of the two tested strains of *Staphylococcus hyicus*, which like *S. aureus* belongs to coagulase-positive staphylococci, and, surprisingly, a type strain of a coagulase-negative *Staphylococcus*--*Staphylococcus lugdunensis* (DSM No. 4804, data not shown).

To evaluate the potential of phiAGO1.3 to control *S. aureus* we tested its lytic activity against agar-embedded cells, planctonic cells and biofilms of 75 *S. aureus* clinical isolates from a diversified collection (Figure [1](#F1){ref-type="fig"}). The phage infected productively 55 (73%) of those strains when tested by a spot test, as indicated by the formation of a lysis zone at high phage doses (10^7^--10^5^ PFU/10 μl), and single plaques or confluent plaques with some borders between them visible at lower phage doses. In the assays of the phage lytic activity in liquid culture a significant decrease of the culture density was observed for 61 (81%) of strains upon addition of phiAGO1.3 (Figure [1](#F1){ref-type="fig"} and Supplementary Figure [3](#SM1){ref-type="supplementary-material"}). This difference in the number of susceptible strains is likely caused by the low efficiency of infection of some of them (e.g., 10250/11) resulting from the action of their restriction systems. Conceivably, the initial infection required some population phages to break the restriction barrier of the infected strain. This in turn could lead to the lytic development of the phage and the release of appropriately modified progeny phages able to infect cells of this strain efficiently. Such effect of a lack of strain-specific DNA modifications in the phage DNA has been observed previously for other staphylococcal obligatorily lytic phages (see, e.g., [@B72]).

![Activity of bacteriophage phiAGO1.3 in lysis of *Staphylococcus aureus* strains of various clonal complexes and in the destruction of their biofilms. Strain numbers are as in the MICROBANK collection, with the exception of laboratory strain RN4220. Environmental and bovine mastitis *S. aureus* isolates are marked by (E) and (M), respectively. Density changes of liquid cultures of *S. aureus* upon addition of phiAGO1.3 are exemplified in Supplementary Figure [3](#SM1){ref-type="supplementary-material"}.](fmicb-09-03227-g001){#F1}

The pattern of the culture density changes upon addition of phiAGO1.3 differed for different *S. aureus* strains. In the case of 44 strains all or nearly all cells in the culture underwent lysis (Supplementary Figure [3A](#SM1){ref-type="supplementary-material"}). For the remaining 17 strains the drop in culture density, even at MOI 1, was small and followed by a plateau (Supplementary Figure [3B](#SM1){ref-type="supplementary-material"}) suggesting that productive infection of some cells may be accompanied by the continuous growth of uninfected or resistant cells.

Fourteen of 75 strains tested did not lyse in liquid cultures upon addition of phiAGO1.3 (Figure [1](#F1){ref-type="fig"} and Supplementary Figure [3C](#SM1){ref-type="supplementary-material"}). Additionally, we could not obtain single plaques in the spot test with those strains at any phage dose, despite the presence of lysis zones at high phage doses. Notably, for the latter strains similar lysis zones were obtained using suspensions of purified phage, indicating that they are not caused by free lysins or bacteriocins but by the phage itself. The observed effect could be caused by so called "lysis from without" or by the activity of bacterial phage defense systems causing death of infected cells to stop the phage spread. Apparently, phiAGO1.3 can adsorb to cells of those strains and penetrate their cell envelopes, but the infection is not productive.

Only three *S. aureus* strains of the entire set tested (RN4220, 3812/16, and 3793/16) appeared to be insensitive to phiAGO1.3 as indicated by the lack of any lysis in the spot tests and in liquid culture treated with the phage. Conceivably, their resistance is due to a lack of appropriate phage receptors.

In the majority of cases *S. aureus* forms biofilms at the site of infection ([@B68]). Thus, we determined the effect of phiAGO1.3 on the biofilm mass of the strains tested (Table [1](#T1){ref-type="table"} and Supplementary Figure [4](#SM1){ref-type="supplementary-material"}). In the case of the strains which could not be infected productively in the former assays, phage addition to the preformed biofilm did not influence the biofilm biomass or caused an increase (from 21% to as much as 108%) or a slight decrease of the biofilm biomass. For all the strains that were productively infected with phiAGO1.3, a significant decrease of biofilm biomass (mostly by over 80%) was observed (see Figure [1](#F1){ref-type="fig"} and Supplementary Figure [4](#SM1){ref-type="supplementary-material"}).

###### 

Number of target sites for the *Staphylococcus aureus* R-M systems of Type I and Type II of known specificities in phiAGO1.3 genome.

  -------------------------------------------------------------------------------------------------------------------------------------
  Clonal complex   HsdS subunit name in REBASE     Generic name    Recognition sequence   Number of targets in phiAGO1.3 DNA   I/T^∗^
  ---------------- ------------------------------- --------------- ---------------------- ------------------------------------ --------
  CC1              S. SauMW2I\                     CC1-1\          CCAY-5-TTAA\           1 0                                  4/5
                   S. SauMW2II                     CC1-2 (CC8-2)   CCAY-6-TGT                                                  

  CC5              S.SauN315II\                    CC5-2\          CCAY-6-GTA\            3 0                                  10/10
                   S.SauN315I                      CC5-1 (CC8-2)   AGG-5-GAT                                                   

  CC8\#                                                                                   0                                    7/8

  CC15             S.SauL3150RFAP                  CC15-1          CAAC-5-RTGA            0                                    4/5

  CC22             S.Sau5096I                      CC22-1          AGG-6-TGAR             5                                    4/4

  CC30             S.SauMRSII\                     CC30-1\         GWAG-5-GAT\            0 0                                  8/8
                   S.SauMRSI                       CC30-2          GGA-7-TCG                                                   

  CC45             S.Sau347I                       CC45-1          GWAG-6-TAAA            0                                    9/9

  CC51             S.SauL30RFAP                    CC51-1          GGA-6-CCT              0                                    NT

  CC59             S.SauSA40ORF370P                CC59-1          GGA-6-RTGT             1                                    1/4

  CC72             S.SauCN10RF415P\                CC72-1\         GARA-6-RTGT\           1 0                                  NT
                   S.SauCN10RF1757P                CC72-2          GGA-7-TGC                                                   

  CC75             S.Saull32ORF3780P\              CC75-1\         CAAG-5-RTC\            2 0                                  NT
                   S.Saull32ORF16570P              CC75-2          CNGA-7-TTYG                                                 

  CC93             S.SauJKDIII\                    CC93-3\         GAAG-5-TAC\            0 3 1 3                              NT
                   S.SauJKDII\                     CC93-2\         or complement\                                              
                   S.SauJKDI                       CC93-1          GGHA-7-TCG\                                                 
                                                                   CAG-6-TTC                                                   

  CC97             S.SauC01791ORFAP                CC97-1          CCAY-6-RTC             0                                    0/1

  CC133            S.Saul330RF451P\                CC133-1\        CAG-5-RTGA\            1 0                                  NT
                   S.Saul330RF1794P                CC133-2         GGA-7-TTRG                                                  

  CC398            S.SauSTORF499PCC398-l CC398-1                   ACC-5-RTGA             5                                    3/4

  CC873            S.Sau323260RFAP                 CC873-1         GAG-6-GAT              5                                    NT

  Sau3A\           R-M Type II enzymes                             GATC\                  2 0                                  
  Sau96I                                                           GGNCC                                                       
  -------------------------------------------------------------------------------------------------------------------------------------

∗

I/T indicates the number of infected strains as compared to the number of tested strains.

\#

indicates that the sequences are the same as CC8-2.

Properties of phiAGO1.3 Contributing to Its Wide *S. aureus* Strain Range
-------------------------------------------------------------------------

*Staphylococcus aureus* protection from invading foreign DNA and from horizontal gene transfer between different lineages is provided mainly by Type I DNA restriction-modification (R-M) systems, which were generally designated as *Sau1* although their methylation specificity varies between different CCs ([@B99]). The ability of phiAGO1.3 to infect productively strains of at least 12 CCs implies that either it lacks the relevant target sequences in its DNA or encodes a potent antirestriction system. The target sequences of certain *S. aureus* R-M systems have been identified ([@B62], [@B63]; [@B64]; [@B74]; [@B67]; [@B15]; [@B18]). The phiAGO1.3 genome carries no recognition sequences for CC1-2, CC8, CC30, CC45, CC51, CC72-2, CC75-2, CC93-3, CC97 and CC133-2 *Sau1* R-M systems, and only single recognition sequences for CC1-1, CC59, CC72-1, CC93-2, and CC133-1 *Sau1* R-M systems (Table [1](#T1){ref-type="table"}). The DNA cleavage by restriction endonucleases of classical Type I R-M systems requires a collision of two enzymes translocating toward each other ([@B85]; [@B27]; [@B40]; [@B80]). Thus, a single site does not suffice for the digestion of infecting linear phage DNA. In addition to Type I R-M systems several *S. aureus* strains encode Type II R-M systems such as Sau3A, Sau96I, and isoschizomers of SmlI that recognize 5′-GATC, 5′-GGNCC, and 5′-CTYRAG sequences, respectively, and cleave them if they are not methylated ([@B88], [@B89]; [@B84]; [@B91]; [@B32]). The genome of phiAGO1.3 contains only two GATC sequences and no GGNCC sequences. Taken together these results indicate that the elimination of certain restriction enzyme recognition sites is the dominant phiAGO1.3 strategy to avoid the activity of host R-M systems.

Killing Efficacy of Its Bacterial Host by phiAGO1.3 and the Establishment of Phage Carrier State
------------------------------------------------------------------------------------------------

The efficacy of a given phage to kill the infected bacteria, so called killing efficacy, is a critical parameter in the evaluation of phage therapeutic potential ([@B13]; [@B52]; [@B2]). The killing efficacy reflects a sum of the bacteria killed as a result of productive phage propagation and those killed without the productive propagation, e.g., by the induction of bacterial apoptosis. Infection of *S. aureus* 80wphwpl with phiAGO1.3 at MOI 1 caused killing of about 74% of cells, whereas the infection at MOI 10 caused killing of 93% of cells.

Irrespective of the MOI used for the infection, the bacteria that survived the infection formed colonies of two morphological types: those resembling colonies of non-infected cells (designated here as WTpt, wild-type colonies after phage treatment) and small, transparent colonies (designated as FTpt, frail type colonies after phage treatment) (Figure [2A](#F2){ref-type="fig"}). The fraction of the latter varied from 20 to 40%. While the transfer of cells from the WTpt colonies to a layer of 80wphwpl cells embedded in soft agar did not cause any effect, the transfer of cells from the FTpt colonies caused the formation of lysis zones of indicator bacteria (Figure [2B](#F2){ref-type="fig"}). The lysis was observed even after the FTpt cells were washed several times before plating. Colony PCR of FTpt bacteria with primers specific for phiAGO1.3 revealed the expected 353-bp product, indicative of the presence of phiAGO1.3 (Figure [2C](#F2){ref-type="fig"}). No product was obtained with WTpt colonies. Clearly, the phenotype of FTpt colonies is associated with the presence of phiAGO1.3 phage or phiAGO1.3 DNA.

![Differentiation of colonies formed by phiAGO1.3-infected cells of *S. aureus* 80wphwpl. **(A)** Different colony morphotypes recovered following phiAGO1.3 infection: wild-type colonies, designated as WTpt (white arrow) and small, transparent colonies designated as FTpt (black arrow). **(B)** Identification of phage-releasing colonies. Single *S. aureus* colonies recovered following phage infection were picked onto a layer of 80wphwpl cells in top soft LB agar, incubated overnight at 37°C, and checked for the presence of a lysis zone (WTpt, white arrow; FTpt, black arrow). **(C)** Presence of phiAGO1.3 in colonies surviving phage infection. PCR with phage-specific primers was used to identify phage DNA. Lanes represent: (1) 1-Kb Plus DNA Ladder (Invitrogen), (2) PCR with no template, (3 and 4) Colony PCR with WTpt and FTpt colonies as a source of template, respectively, (5) PCR with phiAGO1.3 as template. White arrowheads indicate 400- and 300-bp marker.](fmicb-09-03227-g002){#F2}

The Establishment of Equilibrium Between Host Bacteria and phiAGO1.3 in Liquid Cultures
---------------------------------------------------------------------------------------

The optical density of 80wphwpl cultures infected with phiAGO1.3 (10^7^ PFU/ml) began to decrease after 7 h and reached the lowest value (OD~600~ of about 0.2) at 15 h, and then increased to reach a plateau (OD~600~ of about 0.9) at about 25 h (Figure [3](#F3){ref-type="fig"}). The pattern of density changes in the culture of cells derived from WTpt colonies and infected with phiAGO1.3 was similar, consistent with the sensitivity of these cells to phiAGO1.3 (Figure [3Bd](#F3){ref-type="fig"}). In contrast, cultures derived from FTpt colonies behaved differently. In the absence of externally added phiAGO1.3 they grew poorly for the first few hours, then increased the optical density for the next 6 h up to OD~600~ ca. 1.2 and then decreased the optical density to reach a plateau (OD~600~ of about 0.6) at about 26 h (Figure [3A](#F3){ref-type="fig"}, empty circles). A similar pattern of density changes was observed in the FTpt-derived cultures when phiAGO1.3 (10^7^ PFU/ml) was added to the cultures at the beginning of the experiment. This lack of an effect of external phage suggested that either the bacteria in the culture were not accessible to the newly added phages or that the infection by the newly added phages was prevented by other means (Figure [3A](#F3){ref-type="fig"}, black circles). Cells of FTpt-derived cultures taken at the 19-th hour, when a significant decrease of culture density was observed (OD~600~ of about 0.9), formed colonies of WTpt and FTpt types, at ratios varying between apparently identical experiment repetitions (1:1, 2:1, 1:2) despite similar curves of culture optical density changes. The total number of cells in the culture at that time, as calculated from the sum of WTpt and FTpt colonies formed, was 10^8^ CFU/ml, while the total number of phages, as calculated by titration, was 10^9^ PFU/ml. In a sample taken at the 32-nd hour the total number of cells was 10^7^ CFU/ml and of phages -- 10^9^ PFU/ml. Apparently, the phage and the bacteria can reach a kind of equilibrium in which they can stably coexist with each other.

![Properties of *S. aureus* 80wphwpl (WT) and its derivatives recovered from phiAGO1.3-treated cultures (WTpt and FTpt). **(A)** Optical density changes of liquid cell cultures of WT (empty triangles), WTpt (empty squares) and FTpt (empty circles) colonies grown without phiAGO1.3 added and upon addition of phiAGO1.3 (filled triangles, squares, and circles, respectively). Portions of LB medium (190 μl) in duplicate were inoculated with appropriate colonies to OD~600~ of about 0.1--0.2. One culture of each pair was supplemented with 10 μl of phiAGO1.3 suspension in LB (10^9^ PFU/ml) and one (control) with 10 μl LB. Cultures were grown in Bioscreen C at 37°C with shaking. **(Ba-f)** Sensitivity of WT and WTpt- and FTpt-derived *S. aureus* to phiAGO1.3, as measured by a spot test. FTpt-derived cells lysed spontaneously in the top agar (Be) and thus the site of phiAGO1.3 application in Bf is not visible.](fmicb-09-03227-g003){#F3}

We reasoned that the FTpt colonies could not increase in size and could not give rise to a growing liquid culture if they did not contain at least a fraction of cells able to grow and divide. Thus, we tested what kind of cells contribute to the formation of FTpt colonies. Single FTpt colonies (designated as G0 generation) were used as the starting material in these experiments. To decrease the probability of phage release and infection of new cells during cell handling and to slow down cell division, suspensions of cells of single FTpt colonies and dilutions were prepared in ice-cold water and the cells were immediately spread on LB plates (the whole procedure did not exceed 3 min). The FTpt progeny cells formed colonies of both the FTpt and WTpt types. To test whether and to what extent the segregation phenotype is inheritable the whole procedure of cell washing, dilutions and plating was repeated with each next passage of cells of FTpt colonies up to seven rounds. Regardless of the passage the fraction of cells forming FTpt colonies varied between 40 and 90% and did not show any tendency to decrease with subsequent passages. Colonies from all the passages studied were tested for the ability to release phiAGO1.3 by their application on a layer of 80wphwpl cells in soft LCA. All FTpt colonies released the phage, while no WTpt colonies did. Taken together our results demonstrate that FTpt colonies are a mixture of two types of bacterial cells and that the phage carrier state is inheritable. The recurrent segregation of FTpt colonies into phage-releasing cells and phage-free cells sensitive to phage infection ensures a stable co-existence of bacteriophage and its host bacteria.

Isolation of Cells Resistant to Infection With phiAGO1.3
--------------------------------------------------------

When cells of FTpt colonies were suspended in molten LCA medium and poured onto solid LB medium, as is commonly done in the double-layer-agar assay of bacteriophage activity, they formed a lysis zone. However, throughout the lysis zone one could observe single bacterial colonies of various sizes (Figure [4A](#F4){ref-type="fig"}), similarly as in the case of the lysis zones obtained during phiAGO1.3 titration on a layer of 80wphwpl cells with the use of high-titer lysates.

![Emergence of phiAGO1.3-resistant clones among bacteria derived from FTpt colonies. **(A)** Growth of single FTpt-derived colonies on a layer of lysed FTpt-derived cells in soft agar. Single FTpt colony was suspended in LCA and spread on LB agar. Plates were incubated for 24 h at 37°C. Colonies formed were designated RevFT. **(B)** Identification of phiAGO1.3-releasing isolates among RevFT-derived bacteria.](fmicb-09-03227-g004){#F4}

To test whether these colonies release the phage like the FTpt colonies did, cells from the top of the colonies were transferred on a layer of 80wphwpl cells embedded in soft agar. Similarly, like as for the FTpt colonies, lysis zones of the indicator cells were formed around the cells of tested colonies. However, opposite to the test with the FTpt colonies, the intensive growth of bacteria was observed in the center of the lysis zones (compare Figures [2B](#F2){ref-type="fig"} and [4B](#F4){ref-type="fig"}). To distinguish these cells from cells of the parental FTpt colonies they were designated RevFT (reverse colonies of FTpt).

All or some WTpt or RevFT cells could potentially represent phage resistant clones. To verify this possibility they were tested for the sensitivity to infection with phiAGO1.3. Cells from WTpt turned out to be sensitive to phiAGO1.3, as indicated by the ability of phiAGO1.3 to form lysis zones on a layer of these cells in LCA (compare Figures [3Bd](#F3){ref-type="fig"} and [3Bb](#F3){ref-type="fig"}) and by the optical density drop of their cell cultures upon addition of phiAGO1.3 (Figure [3A](#F3){ref-type="fig"}). Most likely, WTpt represent the progeny of cells that avoided the encounter with phiAGO1.3, as happens in killing assay experiments ([@B52]). The results were different for the RevFT colony-derived cells, as they did not lyse upon phiAGO1.3 application (Figure [5Ba](#F5){ref-type="fig"}). Clearly, RevFT are cells that have acquired resistance to phiAGO1.3 (Figure [5](#F5){ref-type="fig"}).

![**(A)** Sensitivity of RevFT-derived bacteria to two unrelated phages, phiAGO1.3 and A5W of *Kayvirus* genus. Optical density changes of RevFT culture cells (white circles) upon addition of phage phiAGO1.3 (black squares) or phage A5W (white squares). **(Ba,b)** Sensitivity of RevFT cells to phiAGO1.3 and A5W, as measured by a spot test.](fmicb-09-03227-g005){#F5}

To check whether the resistance phenotype is stable, RevFT cells were purified by passaging through fresh medium, re-isolated from single colonies and tested for sensitivity to phiAGO1.3 by spotting diluted cell suspension on a layer of LCA soft agar containing phiAGO1.3 (10^9^ PFU/ml). The RevFT-derived cells formed colonies and their number was comparable to that formed by a phiAGO1.3 resistant strain, RN4220 (data not shown). Clearly, the resistance of RevFT cells to phiAGO1.3 is maintained even when their contact with the phage is interrupted.

Certain phages of the genus *Rosenblumvirus* require WTA for adsorption, similarly to the *Kayvirus* genus phages. However, the RevFT cells, despite being resistant to phiAGO1.3 remained sensitive to infection with the *Kayvirus* phage A5W, as indicated by the assays in solid as well as in liquid medium (Figures [5A](#F5){ref-type="fig"} \[black squares\] and 5Bb). Clearly, their resistance is not associated with a change of any surface or internal cell structure of *S. aureus* that could be essential for the sensitivity to A5W.

Identification of RevFT Mutation Associated With the Resistance to phiAGO1.3
----------------------------------------------------------------------------

The stable inheritance of phiAGO1.3 resistance by the progeny of cells forming FTpt colonies prompted us to determine the genomic sequence of several RevFT clones and compare it with the sequence of the parental 80wphwpl strain (80wphwpl_v1 control clone). All nine RevFT isolates sequenced had the substitution of G by T at position 1252 of the *arl* gene. This substitution is a nonsense mutation changing a glycine codon (GGA) to a STOP codon (TGA), which results in the production of the ArlS protein depleted of 34 C-terminal amino acid residues. ArlS is a sensory histidine kinase of the two component *S. aureus* regulatory system ArlRS ([@B30]^[3](#fn03){ref-type="fn"}^). The premature termination of translation in the mutant occurs exactly prior to the conserved GLGL motif which is an essential part of the dimerization and phospho-acceptor domain of ArlS protein (pfam HATPase_c domain) -- one of the essential units of the two-component transduction system ([@B30]; [@B102]). Consistently, the ArlRS system cannot be functional in the mutant.

Therapeutic Potential of phiAGO1.3 to Cure Nematode Infection With *S. aureus* 80wphwpl
---------------------------------------------------------------------------------------

If an equilibrium between a phage and its host bacteria similar to that observed in liquid cultures could be also established in *S. aureus*-infected humans or animals during phage therapy it might preclude the use of phiAGO1.3 for therapeutic purposes. Thus, we tested whether phiAGO1.3 can rescue from death *C. elegans* infected with *S. aureus* 80wphwpl. Figure [6](#F6){ref-type="fig"} show that 80wphwpl is pathogenic to *C. elegans*, causing gradual death of more and more nematodes each day so that only about 20% of them survived at 120 h post-infection. Additionally, none of them produced progeny. Opposite to that over 80% of the nematodes survived when they were treated with just one dose of phiAGO1.3 (10^9^ PFU/ml) 24 h after the infection. Moreover, ca. 100 h after the treatment with phiAGO1.3 they started to produce progeny, indicating the recovery of reproductive potential and thereby prompting us to stop the experiment. Taken together our results demonstrate that the ability of phiAGO1.3 to establish a stable mixed population with its bacterial host and to exist in equilibrium with the host under *in vitro* conditions does not negatively influence the therapeutic potential of phiAGO1.3.

![Antistaphylococcal activity of phiAGO1.3 *in vivo*. Percentage of surviving worms fed *S. aureus* 80wphwpl (untreated control, white diamonds) and treated with phiAGO1.3 (black diamonds). Each value is the mean of six samples from three experiments where the total number of worms was 120. The differences between experiments did not exceed 4% for untreated worms and 1% for phiAGO1.3-treated ones.](fmicb-09-03227-g006){#F6}

Nucleotide Sequence Accession Number
------------------------------------

The genomic sequence of the *S. aureus* 80wphwpl WT, control clone (80wphwpl_v1) has been deposited in the GenBank under the Accession No. [CP034098](CP034098).

Discussion
==========

Carefully selected obligatorily lytic bacteriophages that efficiently kill bacterial pathogens may become the option of choice in the treatment of infections with antibiotic-resistant bacterial strains. However, safe introduction of a phage to therapy requires its biology and outcomes of interactions with its host bacteria *in vitro* and *in vivo* to be examined to the widest extent possible.

Here, we show that the polyvalent staphylococcal lytic podovirus phiAGO1.3 has properties that make it a potential candidate for therapeutic applications, identify factors that contribute to its wide strain range, and prove its therapeutic efficacy in curing a staphylococcal infection of a model nematode, *Caenorhabditis elegans*. Additionally, we demonstrate for the first time for any staphylococcal lytic phage, that phiAGO1.3 and its host bacteria can co-exist in a stable equilibrium which can be maintained owing to the presence in such mixed population of phage-carrier state cells. The ability to form phage-carrier state cells with its host not only does not cause the lack of efficacy of phiAGO1.3 as an antistaphylococcal agent *in vivo*, but also leads to the emergence of phage-resistant host mutants impaired in virulence.

The phiAGO1.3 virion morphology, genomic features and proteome place this phage among typical *Rosenblumvirus* phages, which infect *S. aureus* (Supplementary Table [2](#SM1){ref-type="supplementary-material"}; [@B98]; [@B45]; [@B81]; [@B43]; [@B92]; [@B90]; [@B101]; [@B35]). The host range of only some of them has been studied and varied between 50 and 90% of the *S. aureus* strains tested ([@B81]; [@B43]; [@B92]; [@B101]). However, none of these host-range tests were conducted using the phage propagated in a prophage-free host. Thus, one cannot exclude that the plaques observed with certain strains could represent plaques of a prophage-derived temperate phage. To avoid this ambiguity, we determined the host range of phiAGO1.3 with various representatives of the genus *Staphylococcus* and representatives of 14 *S. aureus* clonal complexes using a prophage-free host for phage propagation. Of 75 *S. aureus* strains tested only some human isolates of CC1, CC59 and CC398, a bovine mastitis isolate of CC97 and isolates of CC7 were resistant to phiAGO1.3. However, despite the lack of productive infection of the majority of these resistant strains, phiAGO1.3 could cause their lysis from without, indicating that the resistance in not caused by a lack of appropriate phage receptors.

The ability of phiAGO1.3 to infect representatives of most of the *S. aureus* CCs requires bypassing of staphylococcal Type I R-M systems (*Sau1*) of different specificities. We show here that the main strategy of phiAGO1.3 to overcome the action of R-M systems of Type I and also Type II is the avoidance or sparcity of DNA sequences recognized by these systems in its genome. This strategy appears to be common to all *Rosenblumvirus* phages. They all lack in their genomes the GGNCC sequences (targets of Sau96I) and usually lack or only have single copies of sequences recognized by certain CC-specific variants of *Sau1* (data not shown).

The absence of the recognition sequences for the *Sau1* R-M systems of certain CCs could in principle be used as a predictor of the strain-range of a phage. Our results indicate that it is often, but not always, true. Some CC22 and CC15 strains tested were infected productively by phiAGO1.3 despite the presence of five recognition sequences for each of the respective *Sau1* systems in the phiAGO1.3 genome. Some phages encode antirestriction proteins protecting phage DNA from the host Type I R-M systems ([@B46]; [@B75]; [@B39]). Although phiAGO1.3 does not encode homologs of known antirestriction proteins, a role of one of its proteins of unassigned function in antirestriction cannot be excluded (Supplementary Table [3](#SM1){ref-type="supplementary-material"}, [@B98]).

Some of the CC1 and CC59 strains tested were susceptible to lysis from without but still could not be infected productively by phiAGO1.3, despite a lack or the presence of only a single copy of recognition sequences for the respective *Sau1* systems in the phage DNA (Table [1](#T1){ref-type="table"}). A likely reason for this could be the action of other R-M systems in these strains. Several *S. aureus* strains encode two related Type I R-M systems ([@B99]; [@B62]; [@B66]; [@B51]) or contain additional R-M system genes on mobile elements, such as prophages, pathogenicity islands, or *SCC-mec* cassettes ([@B37]; [@B23]; [@B70]). Additionally, one cannot exclude a protective activity of CRISPR-Cas systems or abortive infection systems (Abi) ([@B17]; [@B46]), which also have been found in some strains of *S. aureus* ([@B106]; [@B12]; [@B24]). The staphylococcal Abi system involves the serine/threonine kinase Stk2 which is activated by phage proteins during lytic development and causes cell death by phosphorylating essential proteins. Stk2 protects the bacteria from the infection with all siphoviruses tested. Its influence on the sensitivity to podoviruses has not been studied.

Productive infection as well as lysis from without can serve as an indicator of successful phage adsorption to a bacterial cell. Accordingly, phiAGO1.3 could adsorb to all but three *S. aureus* strains tested. One of them is RN4220 whose WTA is modified by the TarM-mediated α-*O*-GlcNAcylation ([@B49]). The inability of phiAGO1.3 to adsorb to RN4220 cells and the high homology of phiAGO1.3 RBP to the RBPs of subgroup I *Rosenblumvirus* phages (Supplementary Table [2](#SM1){ref-type="supplementary-material"}) implies the requirement of WTA β-*O*-GlcNAcylation for phiAGO1.3 adsorption. What causes the sensitivity of certain *S. hyicus* and *S. lugdunensis* strains to phiAGO1.3 is unclear. We detected proteins of only partial homology to the *S. aureus* TarS (which mediates WTA β-*O*-GlcNAcylation) among predicted gene products of both infected strains (data not shown).

The β-*O*-GlcNAcylation of WTA is essential for the expression of methicillin-resistance in *S. aureus* and requires the function of TarS protein ([@B10]). This implies that MRSA strains are likely to adsorb *Rosenbslumvirus* genus phages of subgroup I. In support of that, all three strains that did not adsorb phiAGO1.3 in our tests are MSSA (Figure [1](#F1){ref-type="fig"}).

We show here that under certain conditions the exposure of *S. aureus* cells to phiAGO1.3 can lead to the establishment of a mixed population in which bacteria and bacteriophages are in an equilibrium, and remain in a stable ratio even following several serial passages -- an equivalent of multiple generations. This interaction is reminiscent of so called phage carrier state cultures (PCSCs) ([@B57]). In the PCSC, phage-resistant and phage-sensitive cells co-exist in an equilibrium supporting a continuous growth of the bacterial as well as the phage population ([@B57]; [@B1]). The bacteriophage carrier state has been described for over a dozen of bacteria ([@B36], and references therein), but as far as we know this is the first report of such a relation between staphylococci and their lytic phage.

In PCSCs phage resistance can be determined genetically and associated with the emergence of phage sensitive cells or it can be determined by phenotypic traits only. At least two phage-dependent mechanisms may be responsible for the latter. In the first case, exemplified by P22 PCSC, proteins that determine superinfection immunity of some cells in the population are inherited cytoplasmically by progeny cells despite the loss of P22 resulting from asymmetric cell division ([@B14]). When the phage is removed from the PCSC (e.g., with anti-phage serum) the proportion of cells resistant to superinfection decreases with cell divisions and finally they disappear altogether due to dilution of the immunity factor in the cells. In the second case, uninfected bacteria are modified by soluble factors released from the phage-infected bacteria ([@B1]). For instance lysin released from T7-infected *S. dysenteriae* cells at phage release inactivates the phage receptors of uninfected cells and thus induces a stable equilibrium between infected and non-infected cells ([@B48]). Its concentration decreases with the increasing proportion of modified uninfected cells, until a threshold is reached below which cells recover phage sensitivity ([@B1]). Some bacteria can modify the display of phage receptors or the specificity of their Type I or Type II R-M in the population in a phage-independent manner, e.g., by phase variation ([@B1]; [@B77]; [@B20]; [@B4]; [@B3]; [@B22]). The phage population in this case would be maintained solely by infecting those bacteria in the population that currently display the receptor or do not restrict a given phage DNA. Phase variation is also a cause of intra-populational diversity of certain surface properties in *S. aureus*. For instance the adhesive properties and the ability to form biofilm may be diversified among the cells of a population as a result of reversible insertion/excision of IS256 or the expansion/contraction of a tandem repeat in *icaC* -- a gene involved in the synthesis of poly-*N*-acetylglucosamine (PNAG) which is a major component of the biofilm matrix ([@B42]; [@B5]).

The maintenance of PCSCs can be advantageous to bacterial populations. For instance PCSCs of *Campylobacter jejuni* could serve as phage delivery vectors to new target hosts within pre-colonized chicken, facilitating the acquisition of new environment for the bacteria and for its phage ([@B80]). Here, we show that the ability of bacteriophage phiAGO1.3 to be maintained in the form of a phage carrier state population with its host *S. aureus* strain in laboratory cultures does not preclude its ability to cure *C. elegans* from infection with the same *S. aureus* strain. A few reasons for this discrepancy are possible: (i) the phage carrier state could be limited to certain conditions only and cannot be maintained *in vivo*, (ii) limitation of the bacterial load by phages killing the sensitive fraction of cells suffices for the natural antimicrobial defense of the nematode to combat the infection, (iii) the phage carrier state somehow interferes with the bacterial virulence.

In certain bacterial pathogens phase-variation-dependent phage resistance phenotypes are associated with changes that abolish virulence ([@B77]; [@B20]). The maintenance of the subpopulation of phage susceptible cells may be a temporal cost overweighted by the increased fitness of these pathogens upon infection of a human or animal. We found here that the mutation emerging in the population of 80wphwpl cells infected with phiAGO1.3 and causing the resistance to phiAGO1.3 leads to the synthesis of a truncated inactive version of ArlS protein. ArlS is a part of the two-component ArlR-ArlS system known to affect several functions associated with *S. aureus* virulence and surface properties, either directly or through other regulatory systems, *agr* among them ([@B30]; [@B31]; [@B50]; [@B56]). The ArlRS system is involved in catheter colonization and in endothelial cell damage by *S. aureus* ([@B11]; [@B78]). It is required for establishing invasive *S. aureus* infection and resistance to calprotectin-mediated Mn starvation *in vivo* and has been shown to be essential for pathogenesis in a rabbit model of sepsis and infective endocarditis ([@B100]; [@B73]). Mutations that abolish ArlRS functioning cause, among other defects, the inability of cells to agglutinate, decrease protein A expression in certain media, capsule production and intercellular adhesion, and lead to a serious deficit in the PNAG production ([@B56]; [@B11]; [@B97]).

Certain virulence factors that are down-regulated in the ArlRS-deficient mutant, e.g., the Ser-Asp-rich bone fibronectin-binding proteins SdrC, SdrD, and SdrE ([@B50]) require sortase A (SrtA) to be covalently anchored to the cell wall peptidoglycan ([@B61]). *S. aureus srtA* deletion mutants have been shown to be resistant to infection with phiAGO1.3-related phages 44AHJD, 66 and 68 ([@B49]). It seems plausible that the cell surface change that causes the phiAGO1.3 resistance of *arlS* mutants concerns a sortase-dependent protein. One of the Sdr proteins is a candidate.

A common feature of the *srtA* deletion mutant studied by [@B49] and our *arlS* mutant is their sensitivity to a polyvalent *Kayvirus* phage, K and A5W, respectively. Phage K requires only the WTA backbone for adsorption, independently of WTA modifications ([@B105], [@B104]; [@B49]). Another *Kayvirus*, ϕSA012, contains two RBPs of which one, gp103, binds to α-*O*-GlcNAc substituted WTA and the other, gp105, to the WTA backbone ([@B94]). Of the two RBPs of A5W (gpORF094 \[ACB89087\] and gpORF96 \[ACB89089.1) one is identical with a phage K RBP, while the other is 98% identical to ϕSA012 gp103, implying that phage A5W can use both the WTA backbone and the α-*O-*GlcNAc substituted WTA for adsorption, unlike phiAGO1.3. Thus, phiAGO1.3 appears to be not only a good candidate for a therapeutic use itself but also as a component of therapeutic phage cocktails with A5W and other *Kayvirus* genus phages.
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